These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32413847)

  • 1. An overview of clinical activities in Endo-ERN: the need for alignment of future network criteria.
    de Vries F; Bruin M; Cersosimo A; van Beuzekom CN; Ahmed SF; Peeters RP; Biermasz NR; Hiort O; Pereira AM
    Eur J Endocrinol; 2020 Aug; 183(2):141-148. PubMed ID: 32413847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current landscape of European registries for rare endocrine conditions.
    Ali SR; Bryce J; Cools M; Korbonits M; Beun JG; Taruscio D; Danne T; Dattani M; Dekkers OM; Linglart A; Netchine I; Nordenstrom A; Patocs A; Persani L; Reisch N; Smyth A; Sumnik Z; Visser WE; Hiort O; Pereira AM; Ahmed SF
    Eur J Endocrinol; 2019 Jan; 180(1):89-98. PubMed ID: 30407922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare and Complex Urology: Clinical Overview of ERN eUROGEN.
    Oomen L; Leijte E; Shilhan DE; Battye M; ; Feitz WFJ
    Eur Urol; 2022 Feb; 81(2):204-212. PubMed ID: 33743996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with rare endocrine conditions have corresponding views on unmet needs in clinical research.
    de Graaf JP; de Vries F; Dirkson A; Hiort O; Pereira AM; Korbonits M; Cools M;
    Endocrine; 2021 Mar; 71(3):561-568. PubMed ID: 33534110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supporting international networks through platforms for standardised data collection-the European Registries for Rare Endocrine Conditions (EuRRECa) model.
    Ali SR; Bryce J; Smythe C; Hytiris M; Priego AL; Appelman-Dijkstra NM; Ahmed SF
    Endocrine; 2021 Mar; 71(3):555-560. PubMed ID: 33512655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current clinical practice for thromboprophylaxis management in patients with Cushing's syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN).
    van Haalen FM; Kaya M; Pelsma ICM; Dekkers OM; Biermasz NR; Cannegieter SC; Huisman MV; van Vlijmen BJM; Feelders RA; Klok FA; Pereira AM;
    Orphanet J Rare Dis; 2022 May; 17(1):178. PubMed ID: 35505430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the current transition of care practice for patients with pituitary disease at Endo-ERN reference centers.
    Shishkov SR; Tuccillo L; Iotova VM; Pivonello R; Pelsma IC; Pereira AM; Biermasz NR
    Endocr Connect; 2023 Feb; 12(2):. PubMed ID: 36524809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of the European Society of Endocrinology (ESE) and the European Society of Paediatric Endocrinology (ESPE) on rare endocrine disease.
    Reincke M; Hokken-Koelega A
    Endocrine; 2021 Mar; 71(3):539-541. PubMed ID: 33740222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic reporting of rare endocrine conditions within a clinical network: results from the EuRRECa project.
    Ali SR; Bryce J; Priego-Zurita AL; Cherenko M; Smythe C; de Rooij TM; Cools M; Danne T; Katugampola H; Dekkers OM; Hiort O; Linglart A; Netchine I; Nordenstrom A; Attila P; Persani L; Reisch N; Smyth A; Sumnik Z; Taruscio D; Visser WE; Pereira AM; Appelman-Dijkstra NM; Ahmed SF
    Endocr Connect; 2023 Dec; 12(12):. PubMed ID: 37902973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to Endo-ERN-scope and mission.
    Pereira AM; Hiort O
    Endocrine; 2021 Mar; 71(3):537-538. PubMed ID: 33449294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to patient oriented information-a baseline Endo-ERN survey among patients with rare endocrine disorders.
    Iotova V; Schalin-Jäntti C; Bruegmann P; Broesamle M; De Graaf J; Bratina N; Tillmann V; Pereira AM; Hiort O
    Endocrine; 2021 Mar; 71(3):542-548. PubMed ID: 33599944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Starting point for benchmarking outcomes and reporting of pituitary adenoma surgery within the European Reference Network on Rare Endocrine Conditions (Endo-ERN): results from a meta-analysis and survey study.
    Zamanipoor Najafabadi AH; van der Meulen M; Priego Zurita AL; Faisal Ahmed S; van Furth WR; Charmandari E; Hiort O; Pereira AM; Dattani M; Vitali D; de Graaf JP; Biermasz NR;
    Endocr Connect; 2023 Jan; 12(1):. PubMed ID: 36327151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.
    Casareto L; Appelman-Dijkstra NM; Brandi ML; Chapurlat R; Cormier-Daire V; Hamdy NAT; Heath KE; Horn J; Mantovani G; Mohnike K; Sousa SB; Travessa A; Wekre LL; Zillikens MC; Sangiorgi L;
    Eur J Med Genet; 2024 Apr; 68():104916. PubMed ID: 38296035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Child-to-adult transition: a survey of current practices within the European Reference Network for Rare Neurological Diseases (ERN-RND).
    Nanetti L; Kearney M; Boesch S; Stovickova L; Ortigoza-Escobar JD; Macaya A; Gomez-Andres D; Roze E; Molnar MJ; Wolf NI; Darling A; Vasco G; Bertini E; Indelicato E; Neubauer D; Haack TB; Sagi JC; Danti FR; Sival D; Zanni G; Kolk A; Boespflug-Tanguy O; Schols L; van de Warrenburg B; Vidailhet M; Willemsen MA; Buizer AI; Orzes E; Ripp S; Reinhard C; Moroni I; Mariotti C;
    Neurol Sci; 2024 Mar; 45(3):1007-1016. PubMed ID: 37853291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the outreach of the 2019-2021 Endo-ERN knowledge generation webinars.
    Iotova V; Schalin-Jäntti C; Van Beuzekom C; Bruegmann P; Broesamle M; Hiort O; Pereira AM
    Endocr Connect; 2023 Aug; 12(9):. PubMed ID: 37450855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The experience of diagnosis announcement in rare endocrine diseases: A survey of the French FIRENDO network.
    Rahabi H; Givony M; Demaret B; Albarel F; Aubron MR; Bartès B; Bernard L; Abdoul H; Bouazza N; Brun P; Drui D; Dujardin V; Lançon C; Malivoir S; Netchine I; Perrotin B; Picard V; Reynaud R; Ribeiro M; Tardy Guidollet V; Victor A; Bertherat J; Colin C; Brue T
    Ann Endocrinol (Paris); 2024 Feb; 85(1):27-35. PubMed ID: 37951412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER.
    Bernts LHP; Jones DEJ; Kaatee MM; Lohse AW; Schramm C; Sturm E; Drenth JPH
    Orphanet J Rare Dis; 2019 Jul; 14(1):169. PubMed ID: 31287000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPMS-improving patient care in Europe via virtual case discussions.
    Mönig I; Steenvoorden D; de Graaf JP; Ahmed SF; Taruscio D; Beun JG; Johannsen TH; Juul A; Hiort O; Pereira AM
    Endocrine; 2021 Mar; 71(3):549-554. PubMed ID: 33528763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Evaluation of Rare Pituitary Lesions: A Single Tertiary Care Pituitary Center Experience and Review of the Literature.
    Cossu G; Brouland JP; La Rosa S; Camponovo C; Viaroli E; Daniel RT; Messerer M
    Endocr Pathol; 2019 Sep; 30(3):219-236. PubMed ID: 31209729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.